Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    8709780 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Genetic Response to Warfarin in Healthy Subjects
Condition: Healthy
Intervention: Drug: Warfarin
2 Not yet recruiting Study of Octaplex, a Four-factor Prothrombin Complex Concentrate (4F-PCC) and Beriplex® P/N (Kcentra) for the Reversal of Vitamin K Antagonist (VKA) Induced Anticoagulation in Patients Needing Urgent Surgery With Significant Bleeding Risk.
Condition: Significant Bleeding Risk
Interventions: Drug: Octaplex;   Drug: Beriplex P/N (Kcentra)

Study has passed its completion date and status has not been verified in more than two years.